Log In
BCIQ
Print this Print this
 

TP-4207

  Manage Alerts
Collapse Summary General Information
Company Tolero Pharmaceuticals Inc.
DescriptionBruton's tyrosine kinase (Btk) inhibitor
Molecular Target Bruton's tyrosine kinase (Btk)
Mechanism of ActionBruton's tyrosine kinase (Btk) inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today